A blood-based biomarker panel indicates IL-10 and IL-12/23p40 are jointly associated as predictors of β-amyloid load in an AD cohort

S. Pedrini; V.B. Gupta; E. Hone; J. Doecke; S. O’Bryant; I. James; A.I. Bush; C.C. Rowe; V.L. Villemagne; D. Ames; C.L. Masters; R.N. Martins

doi:10.1038/s41598-017-14020-9

Back

A blood-based biomarker panel indicates IL-10 and IL-12/23p40 are jointly associated as predictors of β-amyloid load in an AD cohort

Journal article

Peer reviewed

A blood-based biomarker panel indicates IL-10 and IL-12/23p40 are jointly associated as predictors of β-amyloid load in an AD cohort

S. Pedrini, V.B. Gupta, E. Hone, J. Doecke, S. O’Bryant, I. James, A.I. Bush, C.C. Rowe, V.L. Villemagne, D. Ames, …

Scientific Reports, Vol.7(1)

2017

DOI: https://doi.org/10.1038/s41598-017-14020-9

Files and links (1)

url

Free to Read *No subscription requiredView

Abstract

Alzheimer’s Disease (AD) is the most common form of dementia, characterised by extracellular amyloid deposition as plaques and intracellular neurofibrillary tangles of tau protein. As no current clinical test can diagnose individuals at risk of developing AD, the aim of this project is to evaluate a blood-based biomarker panel to identify individuals who carry this risk. We analysed the levels of 22 biomarkers in clinically classified healthy controls (HC), mild cognitive impairment (MCI) and Alzheimer’s participants from the well characterised Australian Imaging, Biomarker and Lifestyle (AIBL) study of aging. High levels of IL-10 and IL-12/23p40 were significantly associated with amyloid deposition in HC, suggesting that these two biomarkers might be used to detect at risk individuals. Additionally, other biomarkers (Eotaxin-3, Leptin, PYY) exhibited altered levels in AD participants possessing the APOE ε4 allele. This suggests that the physiology of some potential biomarkers may be altered in AD due to the APOE ε4 allele, a major risk factor for AD. Taken together, these data highlight several potential biomarkers that can be used in a blood-based panel to allow earlier identification of individuals at risk of developing AD and/or early stage AD for which current therapies may be more beneficial.

Details

Title: A blood-based biomarker panel indicates IL-10 and IL-12/23p40 are jointly associated as predictors of β-amyloid load in an AD cohort
Authors/Creators: S. Pedrini (Author/Creator) - Edith Cowan University
V.B. Gupta (Author/Creator) - Edith Cowan University
E. Hone (Author/Creator) - Edith Cowan University
J. Doecke (Author/Creator) - Commonwealth Scientific and Industrial Research Organisation
S. O’Bryant (Author/Creator)
I. James (Author/Creator) - Murdoch University
A.I. Bush (Author/Creator) - Cooperative Research Centre for Mental Health
C.C. Rowe (Author/Creator) - Austin Health
V.L. Villemagne (Author/Creator) - Austin Health
D. Ames (Author/Creator) - National Ageing Research Institute
C.L. Masters (Author/Creator) - Florey Institute of Neuroscience and Mental Health
R.N. Martins (Author/Creator) - Department of Biomedical Sciences
Publication Details: Scientific Reports, Vol.7(1)
Publisher: Springer Nature
Identifiers: 991005543983907891
Murdoch Affiliation: Institute for Immunology and Infectious Diseases
Language: English
Resource Type: Journal article

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

Source: InCites

Metrics

44 Record Views

27 Times Cited - Web of Science

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Domestic collaboration; International collaboration
Citation topics: 1 Clinical & Life Sciences; 1.52 Neurodegenerative Diseases; 1.52.60 Dementia
Web Of Science research areas: Multidisciplinary Sciences
ESI research areas: Neuroscience & Behavior